A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R

被引:107
作者
Deng, XY
Ueda, H
Su, SB
Gong, WH
Dunlop, NM
Gao, JL
Murphy, PM
Wang, JM
机构
[1] NCI, Frederick Canc Res & Dev Ctr, Mol Immunoregulat Lab, Div Basic Sci, Frederick, MD 21702 USA
[2] NCI, Frederick Canc Res & Dev Ctr, SAIC Frederick, Intramural Res Support Program, Frederick, MD 21702 USA
[3] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1182/blood.V94.4.1165.416k23_1165_1173
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Because envelope gp120 of various strains of human immunodeficiency virus type 1 (HIV-1) downregulates the expression and function of a variety of chemoattractant receptors through a process of heterologous desensitization, we investigated whether epitopes derived from gp120 could mimic the effect. A synthetic peptide domain, designated F peptide, corresponding to amino acid residues 414-434 in the V4-C4 region of gp120 of the HIV-1 Bru strain, potently reduced monocyte binding and chemotaxis response to macrophage inflammatory protein 1 beta (MIP-1 beta) and stromal cell-derived factor 1 alpha (SDF-1 alpha), chemokines that use the receptors CCR5 and CXCR4, respectively. Further study showed that F peptide by itself is an inducer of chemotaxis and calcium mobilization in human monocytes and neutrophils. In cross-desensitization experiments, among the numerous chemoattractants tested, only the bacterial chemotactic peptide fMLF, when used at high concentrations, partially attenuated calcium mobilization induced by F peptide in phagocytes, suggesting that this peptide domain might share a 7-transmembrane, G-protein-coupled receptor with fMLF By using cells transfected with cDNAs encoding receptors that interact with fMLF, we found that F peptide uses an fMLF receptor variant, FPRL1, as a functional receptor. The activation of monocytes by F peptide resulted in downregulation of the cell surface expression of CCR5 and CXCR4 in a protein kinase C-dependent manner. These results demonstrate that activation of FPRL1 on human moncytes by a peptide domain derived from HIV-1 gp120 could lead to desensitization of cell response to other chemoattractants. This may explain, at least in part, the initial activation of innate immune responses in HIV-1-infected patients followed by immune suppression.
引用
收藏
页码:1165 / 1173
页数:9
相关论文
共 42 条
[1]   VIRUS-INDUCED NEUTROPHIL DYSFUNCTION - ROLE IN THE PATHOGENESIS OF BACTERIAL-INFECTIONS [J].
ABRAMSON, JS ;
WHEELER, JG .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (07) :643-652
[2]   Chemoattractant receptor cross-desensitization [J].
Ali, H ;
Richardson, RM ;
Haribabu, B ;
Snyderman, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) :6027-6030
[3]   Thrombin primes responsiveness of selective chemoattractant receptors at a site distal to G protein activation [J].
Ali, H ;
Tomhave, D ;
Richardson, RM ;
Haribabu, B ;
Snyderman, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (06) :3200-3206
[4]  
ALI H, 1993, J BIOL CHEM, V268, P24247
[5]  
BADOLATO R, 1995, J IMMUNOL, V155, P4004
[6]   SERUM AMYLOID-A IS A CHEMOATTRACTANT - INDUCTION OF MIGRATION, ADHESION, AND TISSUE INFILTRATION OF MONOCYTES AND POLYMORPHONUCLEAR LEUKOCYTES [J].
BADOLATO, R ;
WANG, JM ;
MURPHY, WJ ;
LLOYD, AR ;
MICHIEL, DF ;
BAUSSERMAN, LL ;
KELVIN, DJ ;
OPPENHEIM, JJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) :203-209
[7]  
BAO L, 1992, Genomics, V13, P437, DOI 10.1016/0888-7543(92)90265-T
[8]   MONOCYTE CHEMOTACTIC PROTEIN-3 (MCP3) INTERACTS WITH MULTIPLE LEUKOCYTE RECEPTORS - C-C-CKR1, A RECEPTOR FOR MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA, RANTES, IS ALSO A FUNCTIONAL RECEPTOR FOR MCP3 [J].
BENBARUCH, A ;
XU, LL ;
YOUNG, PR ;
BENGALI, K ;
OPPENHEIM, JJ ;
WANG, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (38) :22123-22128
[9]  
Berger EA, 1997, AIDS, V11, pS3
[10]   Selective inhibition of N-formylpeptide-induced neutrophil activation by carbamate-modified peptide analogues [J].
Derian, CK ;
Solomon, HF ;
Higgins, JD ;
Beblavy, MJ ;
Santulli, RJ ;
Bridger, GJ ;
Pike, MC ;
Kroon, DJ ;
Fischman, AJ .
BIOCHEMISTRY, 1996, 35 (04) :1265-1269